Humacyte, Inc.

Alpha Healthcare Acquisition Corp. (Nasdaq: AHAC), sponsored by Alpha Healthcare Acquisition Holdings LLC, completed its initial public offering in 2020 with a focus on the healthcare sector. The company filed a 10-Q on August 16, 2021, under accession number 0001213900-21-043027, in connection with its business combination with Humacyte, Inc., a clinical-stage regenerative medicine company developing human acellular vessels for vascular repair and reconstruction. The SPAC merger with Humacyte closed in August 2021, bringing the biotech to public markets under the AHAC ticker. Sign up on SpacDesk to access full filing histories, deal timelines, and analytics across the SPAC universe.